| Burden of general medical conditions among individuals with bipolar disorder AM Kilbourne, JR Cornelius, X Han, HA Pincus, M Shad, I Salloum, ... Bipolar disorders 6 (5), 368-373, 2004 | 502 | 2004 |
| Hippocampal changes associated with early-life adversity and vulnerability to depression U Rao, LA Chen, AS Bidesi, MU Shad, MA Thomas, CL Hammen Biological psychiatry 67 (4), 357-364, 2010 | 464 | 2010 |
| Insight and frontal cortical function in schizophrenia: a review MU Shad, CA Tamminga, M Cullum, GL Haas, MS Keshavan Schizophrenia research 86 (1-3), 54-70, 2006 | 209 | 2006 |
| Insight and prefrontal cortex in first-episode schizophrenia MU Shad, S Muddasani, K Prasad, JA Sweeney, MS Keshavan Neuroimage 22 (3), 1315-1320, 2004 | 185 | 2004 |
| Prefrontal subregions and dimensions of insight in first-episode schizophrenia—a pilot study MU Shad, S Muddasani, MS Keshavan Psychiatry Research: Neuroimaging 146 (1), 35-42, 2006 | 162 | 2006 |
| Gray matter differences between healthy and depressed adolescents: a voxel-based morphometry study MU Shad, S Muddasani, U Rao Journal of child and adolescent psychopharmacology 22 (3), 190-197, 2012 | 106 | 2012 |
| Neurobiological underpinnings of insight deficits in schizophrenia MU Shad, MS Keshavan, CA Tamminga, C Munro Cullum, A David International Review of Psychiatry 19 (4), 437-446, 2007 | 103 | 2007 |
| Efficacy and tolerability of olanzapine in the treatment of schizotypal personality disorder M Keshavan, M Shad, P Soloff, N Schooler Schizophrenia Research 71 (1), 97-101, 2004 | 81 | 2004 |
| The economic consequences of a drug-drug interaction MU Shad, C Marsh, SH Preskorn Journal of clinical psychopharmacology 21 (1), 119-120, 2001 | 79 | 2001 |
| Muscarinic agonists for the treatment of cognition in schizophrenia AK Sellin, M Shad, C Tamminga CNS spectrums 13 (11), 985-996, 2008 | 64 | 2008 |
| Neurobiology of insight deficits in schizophrenia: an fMRI study MU Shad, MS Keshavan Schizophrenia research 165 (2-3), 220-226, 2015 | 61 | 2015 |
| Neurobiology of self-awareness in schizophrenia: an fMRI study MU Shad, MS Keshavan, JL Steinberg, P Mihalakos, BP Thomas, ... Schizophrenia Research 138 (2-3), 113-119, 2012 | 60 | 2012 |
| A possible bupropion and imipramine interaction MU Shad, SH Preskorn Journal of clinical psychopharmacology 17 (2), 118-119, 1997 | 54 | 1997 |
| Racial differences in the treatment of veterans with bipolar disorder AM Kilbourne, MS Bauer, X Han, GL Haas, P Elder, CB Good, M Shad, ... Psychiatric Services 56 (12), 1549-1555, 2005 | 51 | 2005 |
| Hippocampal volume in healthy controls given 3-day stress doses of hydrocortisone ES Brown, H Jeon-Slaughter, H Lu, R Jamadar, S Issac, M Shad, ... Neuropsychopharmacology 40 (5), 1216-1221, 2015 | 48 | 2015 |
| Novel combination strategy to optimize treatment for PTSD MU Shad, AM Suris, CS North Human Psychopharmacology: Clinical and Experimental 26 (1), 4-11, 2011 | 48 | 2011 |
| Neurobiology of decision-making in adolescents MU Shad, AS Bidesi, LA Chen, BP Thomas, M Ernst, U Rao Behavioural brain research 217 (1), 67-76, 2011 | 46 | 2011 |
| Neuropsychiatric aspects of schizophrenia. CA Tamminga, MU Shad, S Ghose American Psychiatric Publishing, Inc., 2008 | 40 | 2008 |
| Antidepressants MU Shad, SH Preskorn Levy RH, Thummel KE, Trager WF, Hansten PD, Eichelbaum M. USA. Lippincott …, 2000 | 39 | 2000 |
| Attenuation of the effects of corticosteroids on declarative memory with lamotrigine ES Brown, J Wolfshohl, MU Shad, M Vazquez, IJ Osuji Neuropsychopharmacology 33 (10), 2376-2383, 2008 | 36 | 2008 |